Continuous glucose monitoring has many benefits and can improve disease management in for both diabetes types.
CMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.
A lack of diversity in clinical trials has hampered health care providers from understanding the nuances of diseases across specific patient populations.
John Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.
FDA approval was granted on September 13, 2024.
Pharmacy schools specialize in training students as experts in patient care—not as expert business owners.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Secukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.
Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
How much progress have we made in developing therapies to treat this common childhood respiratory disorder?
The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.
A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.
Evidence of the relationship between probiotics and antibiotics is lacking.
Evidence of the relationship between probiotics and antibiotics is lacking.
Known as “The Nutrition Pharmacist,” Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
Pharmacists are indispensable members of the disaster relief team, playing a crucial role in ensuring the continuity of care during and after a natural disaster.
In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.
A new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.
Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Evidence of the relationship between probiotics and antibiotics is lacking.
Mitchell Barnett, PharmD, MS, discusses what lessons can be learned from a community pharmacy drug disposal program.
Opioid use disorder during pregnancy is stigmatized, but these patients deserve compassionate, nonjudgmental care.
During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.
Unfortunately, even though the need for making proper dose adjustments for kidney function is well-recognized, clinicians face many challenges in doing so.